Published in J Antimicrob Chemother on March 16, 2007
The Influence of Probiotics on Vancomycin-Resistant Enterococcus | NCT00591474
Removal of antibiotic resistance gene-carrying plasmids from Lactobacillus reuteri ATCC 55730 and characterization of the resulting daughter strain, L. reuteri DSM 17938. Appl Environ Microbiol (2008) 1.49
Safety assessment of probiotics for human use. Gut Microbes (2010) 1.44
Assessment of bacterial antibiotic resistance transfer in the gut. Int J Microbiol (2011) 1.26
Genetic basis of tetracycline resistance in Bifidobacterium animalis subsp. lactis. Appl Environ Microbiol (2010) 1.23
Antibiotic resistance in probiotic bacteria. Front Microbiol (2013) 1.13
Antimicrobial resistance in the food chain: a review. Int J Environ Res Public Health (2013) 1.04
Comparison of broth microdilution, Etest, and agar disk diffusion methods for antimicrobial susceptibility testing of Lactobacillus acidophilus group members. Appl Environ Microbiol (2008) 0.99
Characterization and transfer of antibiotic resistance in lactic acid bacteria from fermented food products. Curr Microbiol (2011) 0.98
Clinical update on linezolid in the treatment of Gram-positive bacterial infections. Infect Drug Resist (2012) 0.95
Update on antibiotic resistance in foodborne Lactobacillus and Lactococcus species. Front Microbiol (2013) 0.95
Antimicrobial activity, antibiotic susceptibility and virulence factors of Lactic Acid Bacteria of aquatic origin intended for use as probiotics in aquaculture. BMC Microbiol (2013) 0.95
Efficacy of Locally Isolated Lactic Acid Bacteria Against Antibiotic-Resistant Uropathogens. Jundishapur J Microbiol (2016) 0.87
Acquired resistance to macrolide-lincosamide-streptogramin antibiotics in lactic Acid bacteria of food origin. Indian J Microbiol (2012) 0.84
Genotypic diversity, antimicrobial resistance, and virulence factors of human isolates and probiotic cultures constituting two intraspecific groups of Enterococcus faecium isolates. Appl Environ Microbiol (2008) 0.84
Bacteriocin production, antibiotic susceptibility and prevalence of haemolytic and gelatinase activity in faecal lactic acid bacteria isolated from healthy Ethiopian infants. Microb Ecol (2012) 0.84
Antibiotic resistance determinants in the interplay between food and gut microbiota. Genes Nutr (2011) 0.83
Microbial characterization of probiotics--advisory report of the Working Group "8651 Probiotics" of the Belgian Superior Health Council (SHC). Mol Nutr Food Res (2013) 0.83
Antibiotic resistance among cultured bacterial isolates from bioethanol fermentation facilities across the United States. Curr Microbiol (2014) 0.83
Antimicrobial activity and antibiotic susceptibility of Lactobacillus and Bifidobacterium spp. intended for use as starter and probiotic cultures. Biotechnol Biotechnol Equip (2014) 0.81
Characterisation of probiotic properties in human vaginal lactobacilli strains. Microb Ecol Health Dis (2016) 0.81
Evolutionary, ecological and biotechnological perspectives on plasmids resident in the human gut mobile metagenome. Bioeng Bugs (2012) 0.80
Intra- and interlaboratory performances of two commercial antimicrobial susceptibility testing methods for bifidobacteria and nonenterococcal lactic acid bacteria. Antimicrob Agents Chemother (2010) 0.79
Ethyl Pyruvate: An Anti-Microbial Agent that Selectively Targets Pathobionts and Biofilms. PLoS One (2016) 0.75
Highly Heterogeneous Probiotic Lactobacillus Species in Healthy Iranians with Low Functional Activities. PLoS One (2015) 0.75
Strain-specific probiotic properties of lactic acid bacteria and their interference with human intestinal pathogens invasion. Gut Pathog (2017) 0.75
Screening of Probiotic Activities of Lactobacilli Strains Isolated from Traditional Tibetan Qula, A Raw Yak Milk Cheese. Asian-Australas J Anim Sci (2016) 0.75
Susceptibility of Pediococcus isolates to antimicrobial compounds in relation to hop-resistance and beer-spoilage. BMC Microbiol (2009) 0.75
Antibiotic multiresistance analysis of mesophilic and psychrotrophic Pseudomonas spp. isolated from goat and lamb slaughterhouse surfaces throughout the meat production process. Appl Environ Microbiol (2014) 0.75
Assessing the Risk of Probiotic Dietary Supplements in the Context of Antibiotic Resistance. Front Microbiol (2017) 0.75
Next-generation probiotics targeting Clostridium difficile through precursor-directed antimicrobial biosynthesis. Infect Immun (2017) 0.75
Detection of antibiotic resistance genes in the feces of young adult Japanese. Biosci Microbiota Food Health (2017) 0.75
Assessment of antibiotic susceptibility in Lactobacillus isolates from chickens. Gut Pathog (2017) 0.75
Antibiotic sensitivity pattern of indigenous lactobacilli isolated from curd and human milk samples. 3 Biotech (2017) 0.75
Functional Profile Evaluation of Lactobacillus fermentum TCUESC01: A New Potential Probiotic Strain Isolated during Cocoa Fermentation. Biomed Res Int (2017) 0.75
Antibiotic resistance-the need for global solutions. Lancet Infect Dis (2013) 15.01
Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J Clin Microbiol (2003) 14.80
Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002. Emerg Infect Dis (2004) 6.00
EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology (2012) 4.83
International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial Infections. Ann Intern Med (2004) 4.75
Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trial. Lancet Infect Dis (2012) 4.62
Community-acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns. Emerg Infect Dis (2002) 4.08
European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinol Suppl (2012) 3.98
Tackling antibiotic resistance. Nat Rev Microbiol (2011) 3.95
Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases. Clin Infect Dis (2004) 3.75
Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries. Lancet Infect Dis (2010) 3.65
Frequent emergence and limited geographic dispersal of methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci U S A (2008) 3.52
Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives. Gut (2011) 3.36
Ready for a world without antibiotics? The Pensières Antibiotic Resistance Call to Action. Antimicrob Resist Infect Control (2012) 3.02
Redefining extended-spectrum beta-lactamases: balancing science and clinical need. J Antimicrob Chemother (2008) 2.88
Antimicrobial drug use and resistance in Europe. Emerg Infect Dis (2008) 2.68
Temporal stability analysis of the microbiota in human feces by denaturing gradient gel electrophoresis using universal and group-specific 16S rRNA gene primers. FEMS Microbiol Ecol (2004) 2.61
A genomic portrait of the emergence, evolution, and global spread of a methicillin-resistant Staphylococcus aureus pandemic. Genome Res (2013) 2.59
European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe (1997-2009). J Antimicrob Chemother (2011) 2.58
Nasal colonization of humans with methicillin-resistant Staphylococcus aureus (MRSA) CC398 with and without exposure to pigs. PLoS One (2009) 2.56
Society's failure to protect a precious resource: antibiotics. Lancet (2011) 2.51
Virulence characteristics of Klebsiella and clinical manifestations of K. pneumoniae bloodstream infections. Emerg Infect Dis (2007) 2.49
Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut (2012) 2.49
Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial. Lancet (2012) 2.35
Multiplex PCR assay for simultaneous detection of nine clinically relevant antibiotic resistance genes in Staphylococcus aureus. J Clin Microbiol (2003) 2.32
European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe. J Antimicrob Chemother (2006) 2.32
A potential virulence gene, hylEfm, predominates in Enterococcus faecium of clinical origin. J Infect Dis (2003) 2.29
Molecular characterization of blaNDM-1 in an Acinetobacter baumannii strain isolated in Germany in 2007. J Antimicrob Chemother (2011) 2.26
Rare occurrence of methicillin-resistant Staphylococcus aureus CC130 with a novel mecA homologue in humans in Germany. PLoS One (2011) 2.18
Development of a multiplex PCR for the detection of asa1, gelE, cylA, esp, and hyl genes in enterococci and survey for virulence determinants among European hospital isolates of Enterococcus faecium. J Clin Microbiol (2004) 2.10
Prevalence and resistance of commensal Staphylococcus aureus, including meticillin-resistant S aureus, in nine European countries: a cross-sectional study. Lancet Infect Dis (2013) 2.04
A timescale for evolution, population expansion, and spatial spread of an emerging clone of methicillin-resistant Staphylococcus aureus. PLoS Pathog (2010) 2.04
Appropriate international measures for outpatient antibiotic prescribing and consumption: recommendations from a national data comparison of different measures. J Antimicrob Chemother (2013) 2.04
Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens. Int J Med Microbiol (2010) 2.00
Emergence of carbapenem-non-susceptible extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates at the university hospital of Tübingen, Germany. J Med Microbiol (2009) 1.97
Biological costs and mechanisms of fosfomycin resistance in Escherichia coli. Antimicrob Agents Chemother (2003) 1.89
How many infections are caused by patient-to-patient transmission in intensive care units? Crit Care Med (2005) 1.87
Dissemination of Escherichia coli with CTX-M type ESBL between humans and yellow-legged gulls in the south of France. PLoS One (2009) 1.87
Comparison and evaluation of real-time PCR, real-time nucleic acid sequence-based amplification, conventional PCR, and serology for diagnosis of Mycoplasma pneumoniae. J Clin Microbiol (2003) 1.87
Evaluation of real-time PCR for detection of and discrimination between Bordetella pertussis, Bordetella parapertussis, and Bordetella holmesii for clinical diagnosis. J Clin Microbiol (2003) 1.85
Evaluation of molecular typing methods in characterizing a European collection of epidemic methicillin-resistant Staphylococcus aureus strains: the HARMONY collection. J Clin Microbiol (2007) 1.85
Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination. Proc Natl Acad Sci U S A (2010) 1.84
Identification of a novel plasmid-mediated colistin-resistance gene, mcr-2, in Escherichia coli, Belgium, June 2016. Euro Surveill (2016) 1.84
Current trends in rapid diagnostics for methicillin-resistant Staphylococcus aureus and glycopeptide-resistant enterococcus species. J Clin Microbiol (2008) 1.81
Mycobacteria in drinking water distribution systems: ecology and significance for human health. FEMS Microbiol Rev (2005) 1.79
Molecular characterization of methicillin-resistant Staphylococcus aureus strains from pet animals and their relationship to human isolates. J Antimicrob Chemother (2005) 1.78
Dissemination of multidrug-resistant bacteria into the Arctic. Emerg Infect Dis (2008) 1.74
Emergence of methicillin-resistant Staphylococcus aureus (MRSA) in different animal species. Int J Med Microbiol (2009) 1.69
Transcription of the phage-encoded Panton-Valentine leukocidin of Staphylococcus aureus is dependent on the phage life-cycle and on the host background. Microbiology (2009) 1.66
Challenging a dogma: antimicrobial susceptibility testing breakpoints for Mycobacterium tuberculosis. Bull World Health Organ (2012) 1.60
In vitro antibacterial activity of the ceftazidime-avibactam (NXL104) combination against Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother (2012) 1.59
Occurrence and spread of antibiotic resistances in Enterococcus faecium. Int J Food Microbiol (2003) 1.55
The European surveillance of antimicrobial consumption (ESAC) point-prevalence survey of antibacterial use in 20 European hospitals in 2006. Clin Infect Dis (2009) 1.53
Surveillance of outpatient antibiotic consumption in Spain according to sales data and reimbursement data. J Antimicrob Chemother (2007) 1.53
Methicillin-resistant and -susceptible Staphylococcus aureus strains of clonal lineages ST398 and ST9 from swine carry the multidrug resistance gene cfr. Antimicrob Agents Chemother (2008) 1.53
Current trends in culture-based and molecular detection of extended-spectrum-β-lactamase-harboring and carbapenem-resistant Enterobacteriaceae. J Clin Microbiol (2012) 1.52
Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis. J Antimicrob Chemother (2009) 1.52
Is there an association between nosocomial infection rates and bacterial cross transmissions? Crit Care Med (2010) 1.47
Isolation and characterization of current human coronavirus strains in primary human epithelial cell cultures reveal differences in target cell tropism. J Virol (2013) 1.47
Evaluation of new broth media for microdilution antibiotic susceptibility testing of Lactobacilli, Pediococci, Lactococci, and Bifidobacteria. Appl Environ Microbiol (2005) 1.47
Intrafamilial spread of highly virulent staphylococcus aureus strains carrying the gene for Panton-Valentine leukocidin. Scand J Infect Dis (2002) 1.46
Severity assessment for lower respiratory tract infections: potential use and validity of the CRB-65 in primary care. Prim Care Respir J (2012) 1.46
A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infect Dis (2014) 1.46
Towards clinical definitions of lower respiratory tract infection (LRTI) for research and primary care practice in Europe: an international consensus study. Prim Care Respir J (2011) 1.45
Evaluation of 12 commercial tests and the complement fixation test for Mycoplasma pneumoniae-specific immunoglobulin G (IgG) and IgM antibodies, with PCR used as the "gold standard". J Clin Microbiol (2005) 1.45
Safety assessment of probiotics for human use. Gut Microbes (2010) 1.44
Detection of Mycoplasma pneumoniae in respiratory samples by real-time PCR using an inhibition control. J Microbiol Methods (2003) 1.44
[Time to abandon "the house wine". Stop for uncritical empiric use of cefuroxime]. Lakartidningen (2009) 1.43
Multiplex PCR for simultaneous detection of macrolide and tetracycline resistance determinants in streptococci. Antimicrob Agents Chemother (2005) 1.42
Development and clinical evaluation of an internally controlled, single-tube multiplex real-time PCR assay for detection of Legionella pneumophila and other Legionella species. J Clin Microbiol (2003) 1.40
The role of horizontal gene transfer in the spread of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli in Europe and Canada. J Antimicrob Chemother (2006) 1.40
Breakpoints for susceptibility testing should not divide wild-type distributions of important target species. Antimicrob Agents Chemother (2009) 1.39
'The body gets used to them': patients' interpretations of antibiotic resistance and the implications for containment strategies. J Gen Intern Med (2011) 1.39
Molecular monitoring of the fecal microbiota of healthy human subjects during administration of lactulose and Saccharomyces boulardii. Appl Environ Microbiol (2006) 1.36
Clonal analysis of Staphylococcus epidermidis isolates carrying or lacking biofilm-mediating genes by multilocus sequence typing. J Clin Microbiol (2005) 1.36
Community acquired pneumonia in primary care. BMJ (2006) 1.35
Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria. Intensive Care Med (2015) 1.34
A sensitive assay for virus discovery in respiratory clinical samples. PLoS One (2011) 1.33
European Surveillance of Antimicrobial Consumption (ESAC): quality indicators for outpatient antibiotic use in Europe. Qual Saf Health Care (2007) 1.32
NDM-1-producing Escherichia coli in Germany. Antimicrob Agents Chemother (2010) 1.30
Antibiotic resistance and molecular epidemiology of Staphylococcus aureus in Nigeria. BMC Microbiol (2011) 1.30
Differences in gut microbiota composition between obese and lean children: a cross-sectional study. Gut Pathog (2013) 1.30
Clusters of infections in horses with MRSA ST1, ST254, and ST398 in a veterinary hospital. Microb Drug Resist (2008) 1.30
Evaluation of chromogenic media for detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2010) 1.30
European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe. J Antimicrob Chemother (2006) 1.29
MRSA transmission on a neonatal intensive care unit: epidemiological and genome-based phylogenetic analyses. PLoS One (2013) 1.29